Sandsynligheden for et dårligt resultat og for udvikling af høje og vedvarende antistoftitre er tilsyneladende højere blandt CRIM - negative patienter (Cross Reactive Immunologic Material, patienter hvor der ikke blev detekteret endogent GAA- protein med Western blot- analyse) end hos CRIM- positive patienter (patienter hvor der blev detekteret endogent GAA- protein med Western blot- analyse).
The probability of a poor outcome and of developing high and sustained antibody titers appears higher among CRIM-negative patients (Cross Reactive Immunologic Material; patients in whom no endogenous GAA protein was detected by Western blot analysis) than among CRIM-positive patients (patients in whom endogenous GAA protein was detected by Western blot analysis).